| |
OMB
APPROVAL OMB |
UNITED
STATES
SECURITIES
AND EXCHANGE COMMISSION
Washington,
D.C. 20549
|
Number:
3235-0167 Expires: August 31, 2027
Estimated average burden hours per response.....1.50 |
| |
|
| FORM 15 |
|
CERTIFICATION
AND NOTICE OF TERMINATION OF REGISTRATION UNDER SECTION 12(g) OF THE SECURITIES EXCHANGE ACT OF 1934 OR SUSPENSION OF DUTY TO FILE REPORTS
UNDER SECTIONS 13 AND 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934.
Commission
File Number 001-41231
TC BIOPHARM (HOLDINGS) PLC
(Exact
name of registrant as specified in its charter)
Maxim
1, 2 Parklands Way, Holytown, Motherwell, ML1 4WR, Scotland, United Kingdom +44 (0) 1698 209100
(Address,
including zip code, and telephone number, including area code, of registrant’s principal executive offices)
American
Depositary Shares, each representing four thousand Ordinary shares, nominal value of £0.000001 per Ordinary share
(Title
of each class of securities covered by this Form)
None
(Titles
of all other classes of securities for which a duty to file reports under section 13(a) or 15(d) remains)
Please
place an X in the box(es) to designate the appropriate rule provision(s) relied upon to terminate or suspend the duty to file reports:
| |
Rule
12g-4(a)(1) |
☒ |
| |
Rule
12g-4(a)(2) |
☐ |
| |
Rule
12h-3(b)(1)(i) |
☒ |
| |
Rule
12h-3(b)(1)(ii) |
☐ |
| |
Rule 15d-6 |
☐ |
| |
Rule
15d-22(b) |
☐ |
Approximate number of holders
of record as of the certification or notice date: 18 Pursuant to the requirements of the Securities Exchange Act of 1934 (Name
of registrant as specified in charter) has caused this certification/notice to be signed on its behalf by the undersigned duly authorized
person.
| Date: |
December
3, 2025 |
|
By: |
/s/
Martin Thorp |
| |
|
|
|
Martin Thorp |
| |
|
|
|
Chief Financial Officer |
| SEC 2069
(08-11) | Potential
persons who are to respond to the collection of information contained in this Form are not required to respond unless the Form displays
a currently valid OMB control number. |
Instruction: This form is required by Rules 12g-4, 12h-3, 15d-6 and 15d-22
of the General Rules and Regulations under the Securities Exchange Act of 1934. The registrant shall file with the Commission three copies
of Form 15, one of which shall be manually signed. It may be signed by an officer of the registrant, by counsel or by any other duly authorized
person. The name and title of the person signing the form shall be typed or printed under the signature.
